â??A COMPARATIVE, RANDOMIZED, DOUBLE BLIND, PARALLEL GROUP, OBSERVATIONAL CLINICAL TRIAL STUDY TO EVALUATE EFFICACY AND SAFETY OF FILMOGEN GLYCEROL THROAT SPRAY CONTAINING CD-CYANIDIN PLANT PREMIX WITH ESSENTIAL OIL VERSUS SALINE SPRAY AS PLACEBO IN THE TREATMENT OF PATIENTS SUFFERING FROM DRY COUGH.â?? - DRY

VITROBIO0 个研究点目标入组 63 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Both male and female, Age between 8 to 65 years old.
•Patients having dry cough (less than 7 days) of any origin with related symptoms as Throat Pain, throat redness, Throat irritation/itching, (Fever if present) (absence of bronchial mucus/phlegm production)
•Not under any antibacterial or antiviral treatment before recruitment.
•Patients ready to abstain from using any drug (which will affect the study outcome) other than Investigational Product for the treatment of the studied condition during the study period (except in cases when patientâ??s condition worsens as per study physician. In this case, Study physician will decide to prescribe antibiotic, if required).
•Ready to abstain from administration of any herbal or ayurvedic treatment or gargles directed to ease coughing or throat parameters, tea, coffee.
•Cooperative and understanding skills.

•Hypersensitivity/ history of allergy to any of the Investigational productâ??s components.
•Patients who had taken any medicated confectionary, throat pastille, spray or any product with demulcent properties, any cough medicines or drugs containing antihistamines within last 72 hours prior to screening.
•Patients taking medications with known cough promoting side effects (e.g., angiotensin converting enzyme inhibitors or angiotensin II receptor blockers) that in the opinion of the investigator are causing symptoms of cough
•Patients with diagnosis of diseases of pneumonia, asthma, sinusitis, allergic rhinitis, as well as heart disease.
•Patients who had used any local anesthetic within the past 24 hours.
•Patients who have used a longer acting or slow release analgesic during the previous 24 hours.

发起方